🇺🇸 FDA

Drug profile · INN

malathion

MALATHION

approved
US status
approved
Patents linked
4
News articles
0

Quick answer

malathion (MALATHION) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN malathion
Brand MALATHION
Route TOPICAL
Formulation LOTION

Related patents

Search patents →

  1. US 9506040

    Prevascularized constructs for implantation to provide blood perfusion

    Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8329753

    Combination of compounds, or a bifunctional compound, that provides fatty acid metabolism and glycolysis inhibition

    Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7052829

    Prevascularized constructs for implantation to provide blood perfusion

    Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7029838

    Prevascularized contructs for implantation to provide blood perfusion

    Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is malathion?

malathion (MALATHION) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for malathion?

MALATHION is a marketed brand name for malathion. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of malathion?

malathion has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.